His lab is focusing on refining the alanine-scanning assay to a few crucial residues that can correctly distinguish amongst fibrils from neurodegenerative tauopathies. He envisions applying this streamlined assay for postmortem neuropathological diagnosis, And maybe for blood screening of tauopathies.Within this assay, scientists increase extracts